A. Kashuba

发表

Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.

A. Nafziger, J. Bertino, R. Kulawy, 2001, Pharmacogenetics.

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping.

G. Kearns, A. Gaedigk, J. Leeder, 1998, Pharmacogenetics.

Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.

G. Kearns, A. Gaedigk, J. Leeder, 1999, Pharmacogenetics.

Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy.

A. Kashuba, C. Ballow, A. Kashuba, 1996, Diagnostic microbiology and infectious disease.

Elvitegravir concentrations in seminal plasma in HIV‐1‐infected men

D. Podzamczer, J. Niubó, L. Acerete, 2017, HIV medicine.

Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy.

A. Nafziger, J. Bertino, A. Kashuba, 1999, The Journal of clinical psychiatry.

Lopinavir/ritonavir Reduces Bupropion Plasma Concentrations in Healthy Subjects

S. Swindells, C. Lindley, G. Yee, 2007, Clinical pharmacology and therapeutics.

Safety and Pharmacokinetics of Multiple‐Dose Anidulafungin in Infants and Neonates

D. Benjamin, M. Cohen-Wolkowiez, E. Capparelli, 2011, Clinical pharmacology and therapeutics.

Pharmacokinetics of two common antiretroviral regimens in older HIV‐infected patients: a pilot study

A. Forrest, A. Corbett, C. Sykes, 2013, HIV medicine.

Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms

A. Nafziger, J. Bertino, A. Kashuba, 1998, Antimicrobial Agents and Chemotherapy.

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

J. Eron, D. Margolis, M. Kearney, 2012, Nature.

Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime

A. Forrest, C. Ballow, A. Kashuba, 1996, Antimicrobial agents and chemotherapy.

Correlation of intrinsic clearance estimates for erythromycin N‐demethylation (ERMND) and midazolam 1′‐hydroxylation (MDZOH) with CYP3A4 and CYP3A5 content using human liver microsomes (HLM)

C. Lindley, R. Hawke, A. Kashuba, 2003 .

Erratum: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

J. Eron, D. Margolis, M. Kearney, 2012, Nature.